ENZO BIOCHEM INC
10-Q, EX-27, 2000-06-14
MEDICAL LABORATORIES
Previous: ENZO BIOCHEM INC, 10-Q, 2000-06-14
Next: ACCESS PHARMACEUTICALS INC, S-3MEF, 2000-06-14



<TABLE> <S> <C>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          JUL-31-2000
<PERIOD-START>                             AUG-01-2000
<PERIOD-END>                               APR-30-2000
<CASH>                                          47,660
<SECURITIES>                                         0
<RECEIVABLES>                                   53,322
<ALLOWANCES>                                  (33,830)
<INVENTORY>                                      1,572
<CURRENT-ASSETS>                                70,847
<PP&E>                                          10,847
<DEPRECIATION>                                 (8,044)
<TOTAL-ASSETS>                                  87,598
<CURRENT-LIABILITIES>                            2,090
<BONDS>                                              0
                                0
                                          0
<COMMON>                                           255
<OTHER-SE>                                      96,437
<TOTAL-LIABILITY-AND-EQUITY>                    87,598
<SALES>                                         35,755
<TOTAL-REVENUES>                                35,755
<CGS>                                           11,592
<TOTAL-COSTS>                                   32,340
<OTHER-EXPENSES>                                12,604
<LOSS-PROVISION>                                 8,144
<INTEREST-EXPENSE>                             (1,807)
<INCOME-PRETAX>                                  5,222
<INCOME-TAX>                                       182
<INCOME-CONTINUING>                              5,040
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     5,040
<EPS-BASIC>                                        .20
<EPS-DILUTED>                                      .19



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission